<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01103115</url>
  </required_header>
  <id_info>
    <org_study_id>AIS_Ca_VitD_01</org_study_id>
    <nct_id>NCT01103115</nct_id>
  </id_info>
  <brief_title>Calcium + Vitamin D Supplementation for Low Bone Mass in Adolescent Idiopathic Scoliosis (AIS)</brief_title>
  <official_title>Can Calcium and Vitamin D Supplementation Improve Bone Mineral Density and Curve Progression in Girls With Adolescent Idiopathic Scoliosis?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Calcium and Vit D supplementation is
      effective for improving low bone mass in Girls with Adolescent Idiopathic Scoliosis (AIS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adolescent Idiopathic Scoliosis (AIS) is a prevalent condition mainly affecting females with
      disease onset at early puberty. It can lead to serious health problems and is associated with
      low bone mass which can persist with growth. Osteopenia is found to be an important
      prognostic factor for curve progression in AIS. Nutritional studies indicated AIS subjects
      had low dietary calcium intake. Evidences suggested that Vit D insufficiency could be present
      in AIS. Calcium and vitamin D supplementation can therefore be a viable treatment option for
      low bone mass in AIS subjects. The primary objective of this prospective randomized
      double-blinded placebo-controlled trial is to find out whether calcium and vitamin D
      supplementation can improve bone mineral density (BMD) in osteopenic AIS subjects. The
      secondary objective of this study is to evaluate whether the supplementation is effective in
      controlling curve progression in AIS.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>2-year time point</time_frame>
    <description>To determine the effects of calcium and vitamin D intervention on improving bone mineral density of skeletally immature AIS girls with low bone mass.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Curve severity</measure>
    <time_frame>2-year time point</time_frame>
    <description>To determine the effects of calcium and vitamin D intervention on preventing curve progression of skeletally immature AIS girls with low bone mass.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">330</enrollment>
  <condition>Scoliosis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in this group will take the placebo tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ca600mg+VitD400IU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive a daily dose of 600 mg elemental calcium and 400 IU vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ca600mg+VitD800IU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>subjects receive a daily dose of 600 mg elemental calcium and 800 IU vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium 600mg plus Vit D 400 IU</intervention_name>
    <description>Daily supplementation with 600mg Calcium plus 400IU Vitamin D3</description>
    <arm_group_label>Ca600mg+VitD400IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium 600mg plus Vit D 800 IU</intervention_name>
    <description>Daily supplementation with 600mg Calcium plus 800IU Vitamin D3</description>
    <arm_group_label>Ca600mg+VitD800IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo tablets</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 11-14 (Tanner stage &lt; IV)

          -  Low BMD (z-score &lt; 0 from age-matched population mean)

          -  Cobb's Angle greater or equal to 15Â°

          -  Presentation at the Scoliosis Clinic without prior treatment for low bone mass.

        Exclusion Criteria:

          -  Scoliosis with any known etiology such as congenital scoliosis, neuromuscular
             scoliosis, scoliosis of metabolic etiology, scoliosis with skeletal dysplasia, or

          -  Patient with known endocrine and connective tissue abnormalities, or

          -  Patient with eating disorders or GI malabsorption disorders or

          -  Prior treatment for low bone mass before being recruited into the study.

          -  Patient currently taking medication that affects bone metabolism eg corticosterone or
             estrogen.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tsz-ping Lam</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong SAR</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ort.cuhk.edu.hk/</url>
    <description>Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong</description>
  </link>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2010</study_first_submitted>
  <study_first_submitted_qc>April 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2010</study_first_posted>
  <last_update_submitted>February 2, 2015</last_update_submitted>
  <last_update_submitted_qc>February 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>CHENG Chun-yiu Jack</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Adolescent Idiopathic Scoliosis</keyword>
  <keyword>AIS</keyword>
  <keyword>low bone mass</keyword>
  <keyword>osteopenia</keyword>
  <keyword>bone health</keyword>
  <keyword>bone density</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scoliosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

